Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands

El-Naggar, 2017 Ellington, 2012, Adenoid cystic carcinoma of the head and neck: incidence and survival trends based on 1973-2007 surveillance, epidemiology, and end results data. [Internet], Cancer, 118, 10.1002/cncr.27408 Orlandi, 2016, Salivary Gland. Photon beam and particle radiotherapy: present and future. [Internet], Oral Oncol, 60, 146, 10.1016/j.oraloncology.2016.06.019 Jensen, 2015, Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy. [Internet], Radiother Oncol, 114, 182, 10.1016/j.radonc.2015.01.002 Terhaard, 2004, Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group. [Internet], Head Neck, 26, 681, 10.1002/hed.10400 Gao, 2013, Clinicopathological study of distant metastases of salivary adenoid cystic carcinoma, Int J Oral Maxillofac Surg, 42, 923, 10.1016/j.ijom.2013.04.006 van Weert, 2013, Adenoid cystic carcinoma of the head and neck: a single-center analysis of 105 consecutive cases over a 30-year period. [Internet], Oral Oncol, 49, 824, 10.1016/j.oraloncology.2013.05.004 Girelli, 2017, Lung metastasectomy in adenoid cystic cancer: is it worth it?, Oral Oncol, 65, 114, 10.1016/j.oraloncology.2016.10.018 Laurie, 2006, Systemic therapy in the palliative management of advanced salivary gland cancers. [Internet], J Clin Oncol, 24, 2673, 10.1200/JCO.2005.05.3025 Thomson, 2015, Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck. [Internet], Head Neck, 37, 182, 10.1002/hed.23577 Ho, 2016, A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma, Ann Oncol, 27, 1902, 10.1093/annonc/mdw287 Tchekmedyian, 2019, Phase II study of lenvatinib in patients with progressive, recurrent or metastatic adenoid cystic carcinoma. [Internet], J Clin Oncol, 37, 1529, 10.1200/JCO.18.01859 Ferrarotto, 2017, Activating NOTCH1 mutations define a distinct subgroup of patients with adenoid cystic carcinoma who have poor prognosis, propensity to bone and liver metastasis, and potential responsiveness to Notch1 inhibitors. [Internet], J Clin Oncol, 35, 352, 10.1200/JCO.2016.67.5264 Ganly, 2015, Nomograms for predicting survival and recurrence in patients with adenoid cystic carcinoma. An international collaborative study [Internet], Eur J Cancer, 51, 2768, 10.1016/j.ejca.2015.09.004 Schemper, 1996, A note on quantifying follow-up in studies of failure time, Control Clin Trials, 17, 343, 10.1016/0197-2456(96)00075-X Ishwaran, 2008, Random survival FORESTS 1, Ann Appl Stat, 2, 841, 10.1214/08-AOAS169 Lagani, 2017, Feature selection with the R Package MXM : discovering statistically equivalent feature subsets, J Stat Softw, 80, 10.18637/jss.v080.i07 Heinze, 2018, Variable selection – a review and recommendations for the practicing statistician [Internet], Biom J, 60, 431, 10.1002/bimj.201700067 Crowson, 2016, Assessing calibration of prognostic risk scores. [Internet], Stat Methods Med Res, 25, 1692, 10.1177/0962280213497434 Sung, 2003, Clinicopathologic predictors and impact of distant metastasis from adenoid cystic carcinoma of the head and neck. [Internet], Arch Otolaryngol Head Neck Surg, 129, 1193, 10.1001/archotol.129.11.1193 Ho, 2019, Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma, J Clin Investig, 129, 4276, 10.1172/JCI128227 Ho, 2013, The mutational landscape of adenoid cystic carcinoma. [Internet], Nat Genet, 45, 791, 10.1038/ng.2643